Search
text"]":["Sanxiang Biotechnology's Clarification on Dai Lizhong Establishing a Nuclear Fusion Firm: Currently, It's Merely the Chairman's Personal Investment Endeavor, With Years of Ongoing Observatio
2 day ago /
Read about 0 minute
Author：小编
On October 9th, in response to reports about Sanxiang Biotechnology's Chairman, Dai Lizhong, setting up a nuclear fusion company, Sanxiang Biotechnology issued a statement. It clarified that Dai Lizhong serves as the investor and the de facto controller of Honghu Fusion (Shanghai) Energy Technology Co., Ltd., owning a 99% share. Nevertheless, this particular venture solely pertains to his personal investment, and he does not engage in the day-to-day management of the company.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
